Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 42 record(s)

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

January 2024

Req # A-2021-024942

Provide all emails sent to/from/cc'ing Douglas Clarke between May 1 to December 16, 2021. Exclude media scans.

Organization: Patented Medicine Prices Review Board Canada

3229 page(s)
September 2023

Req # A-2023-36126

When referring to page numbers below, I mean the pages in the Client Package disclosed under A-2022-05111. Specifically, I would like to request the following: 1. The "Board deck" (presumably a PowerPoint presentation) mentioned on pages 21-27. 2. The powerpoint attached to the email on page 47, which apparently deals with discrepancies between dTCC data. 3. The media lines attached to the email on page 95. 4. The excel sheet attached to the email on page 98. 5. The presentation attached to the email on page 135. 6. Both attachments to the email on page 135, plus the two documents that are linked to in the email: the impact estimates and communication plan. 7. The attachment to the email on page 142. 8. The "Key messages" document linked to in the body of the email on page 145. 9. The Excel file attached to the email on page 165. 10. I would like any contextual documents related to the document which appears on pages 359-360 ("Brochure: 2020 Rent Increase Guidelines). I imagine this was an attachment to an email, in which case I would like the email (possibly pages 4368-4369 of the raw request). I would also like to request any other documents related to how the brochure was located by the PMPRB, or what use was made of the Brochure by the PMPRB (like subsequent email discussions or meeting agendas which list this document, or reports or memos written about this document, etc). In each case, I would like the most recent or final version. I do not need drafts. Please exclude cabinet confidences.

Organization: Patented Medicine Prices Review Board Canada

17 page(s)
September 2023

Req # A-2022-09060

Recordings or transcripts of both of the French language webinars given by the PMPRB on November 8th, 2022, including any audience questions and the PMPRB's responses. Copies of the English and French PowerPoint for the industry specific webinars held on November 8th, 2022.

Organization: Patented Medicine Prices Review Board Canada

134 page(s)
January 2023

Req # A-2022-09061

Copy of the resignation letter of the Vice-Chair Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
January 2023

Req # A-2022-01918

Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2022

Req # A-2021-10762

Provide all emails, preparation documents, and similar materials that Douglas Clark and other PMPRB executives sent or received related to the recent statement given to the Hill Times for their May 25th article. Include, but do not limit the scope of the request to, emails related to the drafting of the statement.

Organization: Patented Medicine Prices Review Board Canada

21 page(s)
January 2022

Req # A-2021-10767

Copies of all briefing material provided to Douglas Clark from May 22, 2021 to June 11, 2021.

Organization: Patented Medicine Prices Review Board Canada

15 page(s)
January 2022

Req # A-2021-24151

All data source files used to produce the CompassRx 7th Edition Annual Public Drug Plan Expenditure Report, 2019/20, published November 2021 and available here:https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/compassrx-7th-edition.html and here:https://www.canada.ca/content/dam/pmprb-cepmb/documents/npduis/analytical-studies/compassrx-7th-edition/NPDUIS-CompassRx7th-2019-2020_en.pdf.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
January 2022

Req # A-2021-24939

Copies of the preparation documents, meeting summaries and emails related to the weekly meetings between Douglas Clark and Mitchell Levine from May 1, 2021 to December 20, 2021.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
January 2022
Date modified: